About
Technology
Issues
FAQ
Links
Official Page
Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.